메뉴 건너뛰기




Volumn 319, Issue 6, 2018, Pages 595-606

Screening for ovarian cancer updated evidence report and systematic review for the US preventive services task force

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

EID: 85042038935     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.21421     Document Type: Review
Times cited : (283)

References (55)
  • 1
    • 85042013874 scopus 로고    scopus 로고
    • US Cancer StatisticsWorking Group, Accessed June 28, 2017, Centers for Disease Control and Prevention website
    • US Cancer StatisticsWorking Group. United States Cancer Statistics (USCS): 1999-2014 cancer incidence and mortality data. Centers for Disease Control and Prevention website. https://www.cdc .gov/cancer/npcr/uscs/index.htm. 2017. Accessed June 28, 2017.
    • (2017) United States Cancer Statistics (USCS): 1999-2014 Cancer Incidence and Mortality Data
  • 2
    • 79952945610 scopus 로고    scopus 로고
    • SEER (Surveillance, Epidemiology, and End Results Program), Accessed November 2, 2016.
    • SEER (Surveillance, Epidemiology, and End Results Program). SEER Stat Fact Sheets: Ovarian cancer. https://seer.cancer.gov/statfacts/html/ovary .html. Accessed November 2, 2016.
    • SEER Stat Fact Sheets: Ovarian Cancer
  • 3
    • 85015908413 scopus 로고    scopus 로고
    • Screening for gynecologic conditions with pelvic examination: US Preventive Services Task Force recommendation statement
    • US Preventive Services Task Force
    • Bibbins-Domingo K, Grossman DC, Curry SJ, et al; US Preventive Services Task Force. Screening for gynecologic conditions with pelvic examination: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(9): 947-953.
    • (2017) JAMA. , vol.317 , Issue.9 , pp. 947-953
    • Bibbins-Domingo, K.1    Grossman, D.C.2    Curry, S.J.3
  • 4
    • 84867136524 scopus 로고    scopus 로고
    • Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement
    • U.S. Preventive Services Task Force
    • Moyer VA; U.S. Preventive Services Task Force. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2012;157(12):900-904.
    • (2012) Ann Intern Med. , vol.157 , Issue.12 , pp. 900-904
    • Moyer, V.A.1
  • 6
    • 77649246296 scopus 로고    scopus 로고
    • US Preventive Services Task Force, Rockville, MD: US Preventive Services Task Force
    • US Preventive Services Task Force. U.S. Preventive Services Task Force Procedure Manual. Rockville, MD: US Preventive Services Task Force; 2015.
    • (2015) U.S. Preventive Services Task Force Procedure Manual
  • 10
    • 84882451638 scopus 로고    scopus 로고
    • Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis
    • Reade CJ, Riva JJ, Busse JW, Goldsmith CH, Elit L. Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis. Gynecol Oncol. 2013;130(3):674-681.
    • (2013) Gynecol Oncol. , vol.130 , Issue.3 , pp. 674-681
    • Reade, C.J.1    Riva, J.J.2    Busse, J.W.3    Ch, G.4    Elit, L.5
  • 11
    • 85034109734 scopus 로고    scopus 로고
    • Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival
    • Temkin SM, Miller EA, Samimi G, Berg CD, Pinsky P, Minasian L. Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival. Eur J Cancer. 2017;87:182-188.
    • (2017) Eur J Cancer. , vol.87 , pp. 182-188
    • Temkin, S.M.1    Miller, E.A.2    Samimi, G.3    Berg, C.D.4    Pinsky, P.5    Minasian, L.6
  • 12
    • 0035318124 scopus 로고    scopus 로고
    • Current methods of the US Preventive Services Task Force: A review of the process
    • Methods Work Group, Third US Preventive Services Task Force
    • Harris RP, Helfand M, Woolf SH, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: A review of the process. Am J Prev Med. 2001;20(3)(suppl):21-35.
    • (2001) Am J Prev Med. , vol.20 , Issue.3 , pp. 21-35
    • Harris, R.P.1    Helfand, M.2    Woolf, S.H.3
  • 13
    • 84959862763 scopus 로고    scopus 로고
    • Tumors of the peritoneum: Epithelial tumors of Müllerian type
    • In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, eds., Lyon, France: International Agency for Research on Cancer
    • Daya D, Cheung A, Khunamornpong S, et al. Tumors of the peritoneum: Epithelial tumors of Müllerian type. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, eds. WHO Classification of Tumors of Female Reproductive Organs. 4th ed. Lyon, France: International Agency for Research on Cancer; 2014:92-93.
    • (2014) WHO Classification of Tumors of Female Reproductive Organs. 4th Ed. , pp. 92-93
    • Daya, D.1    Cheung, A.2    Khunamornpong, S.3
  • 14
    • 84891161285 scopus 로고    scopus 로고
    • Staging classification for cancer of the ovary, fallopian tube, and peritoneum
    • FIGO Committee on Gynecologic Oncology
    • Prat J; FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1-5.
    • (2014) Int J Gynaecol Obstet. , vol.124 , Issue.1 , pp. 1-5
    • Prat, J.1
  • 15
    • 80052135846 scopus 로고    scopus 로고
    • Morphological subtypes of ovarian carcinoma: A review with emphasis on new developments and pathogenesis
    • McCluggageWG. Morphological subtypes of ovarian carcinoma: A review with emphasis on new developments and pathogenesis. Pathology. 2011; 43(5):420-432.
    • (2011) Pathology. , vol.43 , Issue.5 , pp. 420-432
    • McCluggage, W.G.1
  • 16
    • 84962496502 scopus 로고    scopus 로고
    • The dualistic model of ovarian carcinogenesis: Revisited, revised, and expanded
    • Kurman RJ, Shih IeM. The dualistic model of ovarian carcinogenesis: Revisited, revised, and expanded. Am J Pathol. 2016;186(4):733-747.
    • (2016) Am J Pathol. , vol.186 , Issue.4 , pp. 733-747
    • Kurman, R.J.1    Shihie, M.2
  • 17
    • 84899145661 scopus 로고    scopus 로고
    • The fallopian tube as the origin of high grade serous ovarian cancer: Review of a paradigm shift
    • Reade CJ, McVey RM, Tone AA, et al. The fallopian tube as the origin of high grade serous ovarian cancer: Review of a paradigm shift. J Obstet Gynaecol Can. 2014;36(2):133-140.
    • (2014) J Obstet Gynaecol Can. , vol.36 , Issue.2 , pp. 133-140
    • Reade, C.J.1    McVey, R.M.2    Tone, A.A.3
  • 18
    • 77953395873 scopus 로고    scopus 로고
    • CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials
    • CONSORT Group
    • Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726-732.
    • (2010) Ann Intern Med. , vol.152 , Issue.11 , pp. 726-732
    • Schulz, K.F.1    Altman, D.G.2    Moher, D.3
  • 20
    • 27544448084 scopus 로고    scopus 로고
    • Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screen of a randomized trial
    • PLCO Project Team
    • Buys SS, Partridge E, Greene MH, et al; PLCO Project Team. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193(5):1630-1639.
    • (2005) Am J Obstet Gynecol. , vol.193 , Issue.5 , pp. 1630-1639
    • Buys, S.S.1    Partridge, E.2    Greene, M.H.3
  • 21
    • 79958036419 scopus 로고    scopus 로고
    • Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial
    • PLCO Project Team
    • Buys SS, Partridge E, Black A, et al; PLCO Project Team. Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011;305(22):2295-2303.
    • (2011) JAMA. , vol.305 , Issue.22 , pp. 2295-2303
    • Buys, S.S.1    Partridge, E.2    Black, A.3
  • 22
    • 63149087256 scopus 로고    scopus 로고
    • Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    • Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327-340.
    • (2009) Lancet Oncol. , vol.10 , Issue.4 , pp. 327-340
    • Menon, U.1    Gentry-Maharaj, A.2    Hallett, R.3
  • 23
    • 84957680337 scopus 로고    scopus 로고
    • Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    • Sharma A, Burnell M, Gentry-Maharaj A, et al. Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Ultrasound Obstet Gynecol. 2016;47(2):228-235.
    • (2016) Ultrasound Obstet Gynecol. , vol.47 , Issue.2 , pp. 228-235
    • Sharma, A.1    Burnell, M.2    Gentry-Maharaj, A.3
  • 24
    • 84943139487 scopus 로고    scopus 로고
    • Psychosocial factors associated with withdrawal from the United Kingdom Collaborative Trial of Ovarian Cancer Screening after 1 episode of repeat screening
    • Jenkins V, Fallowfield L, Langridge C, et al. Psychosocial factors associated with withdrawal from the United Kingdom Collaborative Trial of Ovarian Cancer Screening after 1 episode of repeat screening. Int J Gynecol Cancer. 2015;25(8):1519-1525.
    • (2015) Int J Gynecol Cancer. , vol.25 , Issue.8 , pp. 1519-1525
    • Jenkins, V.1    Fallowfield, L.2    Langridge, C.3
  • 25
    • 84904808256 scopus 로고    scopus 로고
    • Psychological morbidity associated with ovarian cancer screening: Results from more than 23, 000 women in the randomised trial of ovarian cancer screening (UKCTOCS)
    • UKCTOCS Trialists
    • Barrett J, Jenkins V, Farewell V, et al; UKCTOCS Trialists. Psychological morbidity associated with ovarian cancer screening: Results from more than 23, 000 women in the randomised trial of ovarian cancer screening (UKCTOCS). BJOG. 2014;121(9): 1071-1079.
    • (2014) BJOG. , vol.121 , Issue.9 , pp. 1071-1079
    • Barrett, J.1    Jenkins, V.2    Farewell, V.3
  • 26
    • 84874039085 scopus 로고    scopus 로고
    • Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial
    • Pinsky PF, Zhu C, Skates SJ, et al. Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial. Int J Cancer. 2013;132(9):2127-2133.
    • (2013) Int J Cancer. , vol.132 , Issue.9 , pp. 2127-2133
    • Pinsky, P.F.1    Zhu, C.2    Skates, S.J.3
  • 27
    • 67249153691 scopus 로고    scopus 로고
    • Cumulative incidence of false-positive results in repeated, multimodal cancer screening
    • Croswell JM, Kramer BS, Kreimer AR, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med. 2009;7(3):212-222.
    • (2009) Ann Fam Med. , vol.7 , Issue.3 , pp. 212-222
    • Croswell, J.M.1    Kramer, B.S.2    Kreimer, A.R.3
  • 28
    • 65649129680 scopus 로고    scopus 로고
    • Results from four rounds of ovarian cancer screening in a randomized trial
    • PLCO Project Team
    • Partridge E, Kreimer AR, Greenlee RT, et al; PLCO Project Team. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol. 2009;113(4):775-782.
    • (2009) Obstet Gynecol. , vol.113 , Issue.4 , pp. 775-782
    • Partridge, E.1    Kreimer, A.R.2    Greenlee, R.T.3
  • 29
    • 34648831557 scopus 로고    scopus 로고
    • Changes in cancer worry associated with participation in ovarian cancer screening
    • Andersen MR, Drescher CW, Zheng Y, et al. Changes in cancer worry associated with participation in ovarian cancer screening. Psychooncology. 2007;16(9):814-820.
    • (2007) Psychooncology. , vol.16 , Issue.9 , pp. 814-820
    • Andersen, M.R.1    Drescher, C.W.2    Zheng, Y.3
  • 31
    • 84959863810 scopus 로고    scopus 로고
    • Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial
    • 10022
    • Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial. Lancet. 2016;387(10022):945-956.
    • (2016) Lancet. , vol.387 , pp. 945-956
    • Jacobs, I.J.1    Menon, U.2    Ryan, A.3
  • 32
    • 0027405117 scopus 로고
    • Prevalence screening for ovarian cancer in postmenopausal women by CA-125 measurement and ultrasonography
    • Jacobs I, Davies AP, Bridges J, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA-125 measurement and ultrasonography. BMJ. 1993;306(6884):1030-1034.
    • (1993) BMJ. , vol.306 , Issue.6884 , pp. 1030-1034
    • Jacobs, I.1    Davies, A.P.2    Bridges, J.3
  • 33
    • 0033541548 scopus 로고    scopus 로고
    • Screening for ovarian cancer: A pilot randomised controlled trial
    • Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: A pilot randomised controlled trial. Lancet. 1999;353(9160):1207-1210.
    • (1999) Lancet. , vol.353 , Issue.9160 , pp. 1207-1210
    • Jacobs, I.J.1    Skates, S.J.2    MacDonald, N.3
  • 34
    • 84930654984 scopus 로고    scopus 로고
    • Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
    • Menon U, Ryan A, Kalsi J, et al. Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. J Clin Oncol. 2015;33(18):2062-2071.
    • (2015) J Clin Oncol. , vol.33 , Issue.18 , pp. 2062-2071
    • Menon, U.1    Ryan, A.2    Kalsi, J.3
  • 35
    • 84995426666 scopus 로고    scopus 로고
    • Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up
    • Pinsky PF, Yu K, Kramer BS, et al. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gynecol Oncol. 2016;143(2):270-275.
    • (2016) Gynecol Oncol. , vol.143 , Issue.2 , pp. 270-275
    • Pinsky, P.F.1    Yu, K.2    Kramer, B.S.3
  • 36
    • 84967318147 scopus 로고    scopus 로고
    • Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer
    • Lai T, Kessel B, Ahn HJ, Terada KY. Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer. J Gynecol Oncol. 2016;27(4):e41.
    • (2016) J Gynecol Oncol. , vol.27 , Issue.4 , pp. e41
    • Lai, T.1    Kessel, B.2    Ahn, H.J.3    Terada, K.Y.4
  • 37
    • 84866521243 scopus 로고    scopus 로고
    • Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening
    • Drescher CW, Hawley S, Thorpe JD, et al. Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening. Cancer Prev Res (Phila). 2012;5(8):1015-1024.
    • (2012) Cancer Prev Res (Phila). , vol.5 , Issue.8 , pp. 1015-1024
    • Drescher, C.W.1    Hawley, S.2    Thorpe, J.D.3
  • 38
    • 62149132122 scopus 로고    scopus 로고
    • Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    • Gren L, Broski K, Childs J, et al. Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Clin Trials. 2009;6(1):52-59.
    • (2009) Clin Trials. , vol.6 , Issue.1 , pp. 52-59
    • Gren, L.1    Broski, K.2    Childs, J.3
  • 39
    • 0344270007 scopus 로고    scopus 로고
    • Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women
    • Skates SJ, Menon U, MacDonald N, et al. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol. 2003;21(10) (suppl):206s-210s.
    • (2003) J Clin Oncol. , vol.21 , Issue.10 , pp. 206s-210s
    • Skates, S.J.1    Menon, U.2    MacDonald, N.3
  • 40
    • 1542678929 scopus 로고    scopus 로고
    • Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers
    • Skates SJ, Pauler DK, Jacobs IJ. Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers. J AmStat Assoc. 2001;26:429-439.
    • (2001) J AmStat Assoc. , vol.26 , pp. 429-439
    • Skates, S.J.1    Pauler, D.K.2    Jacobs, I.J.3
  • 41
    • 85042012153 scopus 로고    scopus 로고
    • The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Performance and complications
    • Doroudi M, Kramer BS, Pinsky PF. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Performance and complications. J Med Screen. 2017;24(4):220-222.
    • (2017) J Med Screen. , vol.24 , Issue.4 , pp. 220-222
    • Doroudi, M.1    Kramer, B.S.2    Pinsky, P.F.3
  • 42
    • 84894265334 scopus 로고    scopus 로고
    • Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations
    • Gewandter JS, Smith SM, McKeown A, et al. Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 2014;155(3):461-466.
    • (2014) Pain. , vol.155 , Issue.3 , pp. 461-466
    • Gewandter, J.S.1    Smith, S.M.2    McKeown, A.3
  • 43
    • 77950273246 scopus 로고    scopus 로고
    • CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
    • Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
    • (2010) BMJ. , vol.340 , pp. c869
    • Moher, D.1    Hopewell, S.2    Schulz, K.F.3
  • 45
    • 84901292378 scopus 로고    scopus 로고
    • Recent concepts of ovarian carcinogenesis: Type i and type II
    • Koshiyama M, Matsumura N, Konishi I. Recent concepts of ovarian carcinogenesis: Type I and type II. Biomed Res Int. 2014;2014:934261.
    • (2014) Biomed Res Int. , vol.2014 , pp. 934261
    • Koshiyama, M.1    Matsumura, N.2    Konishi, I.3
  • 46
    • 79959328816 scopus 로고    scopus 로고
    • Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm
    • Kurman RJ, Shih IeM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol. 2011;42 (7):918-931.
    • (2011) Hum Pathol. , vol.42 , Issue.7 , pp. 918-931
    • Kurman, R.J.1    Shihie, M.2
  • 47
    • 85042030544 scopus 로고    scopus 로고
    • Institute of Medicine, Committee on the State of the Science in Ovarian Cancer Research, Board on Health Care Services, National Academies of Sciences, Engineering, and Medicine, Washington, DC: National Academies Press; 2016.
    • Institute of Medicine, Committee on the State of the Science in Ovarian Cancer Research, Board on Health Care Services, National Academies of Sciences, Engineering, and Medicine. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: National Academies Press; 2016.
    • Ovarian Cancers: Evolving Paradigms in Research and Care
  • 49
    • 84981276294 scopus 로고    scopus 로고
    • Salpingo-oophorectomy at the time of benign hysterectomy: A systematic review
    • Society of Gynecologic Surgeons Systematic Review Group
    • Evans EC, Matteson KA, Orejuela FJ, et al; Society of Gynecologic Surgeons Systematic Review Group. Salpingo-oophorectomy at the time of benign hysterectomy: A systematic review. Obstet Gynecol. 2016;128(3):476-485.
    • (2016) Obstet Gynecol. , vol.128 , Issue.3 , pp. 476-485
    • Evans, E.C.1    Matteson, K.A.2    Orejuela, F.J.3
  • 50
    • 77952878109 scopus 로고    scopus 로고
    • Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004
    • Lowder JL, Oliphant SS, Ghetti C, Burrows LJ, Meyn LA, Balk J. Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004. Am J Obstet Gynecol. 2010;202(6): 538.e1-538.e9.
    • (2010) Am J Obstet Gynecol. , vol.202 , Issue.6 , pp. 538e1-538e9
    • Lowder, J.L.1    Oliphant, S.S.2    Ghetti, C.3    Burrows, L.J.4    Meyn, L.A.5    Balk, J.6
  • 51
    • 84903378966 scopus 로고    scopus 로고
    • Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies
    • Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies. Fertil Steril. 2014;102(1):192-198.
    • (2014) Fertil Steril. , vol.102 , Issue.1 , pp. 192-198
    • Rice, M.S.1    Hankinson, S.E.2    Tworoger, S.S.3
  • 52
    • 85009758047 scopus 로고    scopus 로고
    • Novel risk models for early detection and screening of ovarian cancer
    • Russell MR, D'Amato A, Graham C, et al. Novel risk models for early detection and screening of ovarian cancer. Oncotarget. 2017;8(1):785-797.
    • (2017) Oncotarget. , vol.8 , Issue.1 , pp. 785-797
    • Russell, M.R.1    D'Amato, A.2    Graham, C.3
  • 53
    • 43449104703 scopus 로고    scopus 로고
    • A randomized study of screening for ovarian cancer: A multicenter study in Japan
    • Kobayashi H, Yamada Y, Sado T, et al. A randomized study of screening for ovarian cancer: A multicenter study in Japan. Int J Gynecol Cancer. 2008;18(3):414-420.
    • (2008) Int J Gynecol Cancer. , vol.18 , Issue.3 , pp. 414-420
    • Kobayashi, H.1    Yamada, Y.2    Sado, T.3
  • 54
    • 81855216360 scopus 로고    scopus 로고
    • Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening
    • van Nagell JR Jr, Miller RW, DeSimone CP, et al. Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol. 2011;118(6):1212-1221.
    • (2011) Obstet Gynecol. , vol.118 , Issue.6 , pp. 1212-1221
    • Van Nagell, J.R.1    Miller, R.W.2    De Simone, C.P.3
  • 55
    • 85042016906 scopus 로고    scopus 로고
    • Complications from surgeries prompted by ovarian cancer screening
    • Miller RW, Pavlik EJ, Baldwin LA, et al. Complications from surgeries prompted by ovarian cancer screening. Gynecol Oncol. 2015;137(suppl 1):180.
    • (2015) Gynecol Oncol. , vol.137 , pp. 180
    • Miller, R.W.1    Pavlik, E.J.2    Baldwin, L.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.